Table 3. Results of Univariate Analysis of Potential Risk Factors for Osteoporosis.
Femoral Neck | Lumbar Spine | Total Hip | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
No OP N=225 | OP N=33 | p-value | No OP N=234 | OP N=24 | p-value | No OP N=243 | OP N=15 | p-value | |
| |||||||||
Age (years) | 48 | 50 | 0.74 | 48.7 | 41.9 | 0.074 | 48.5 | 44.1 | 0.10 |
| |||||||||
Body Weight (kg) | 72.6 | 58.4 | <0.0001 | 72.5 | 55.5 | 0.0002 | 72.6 | 53.6 | <0.0001 |
| |||||||||
BMI (kg/m2) | 24.7 | 20.5 | 0.0004 | 24.8 | 19.7 | <0.0001 | 24.6 | 19.4 | 0.0003 |
| |||||||||
Average NIH Organ Scorea | 1.1 | 1.4 | 0.038 | 1.1 | 1 | 0.71 | 1.1 | 1 | 0.45 |
| |||||||||
25-OH Vitamin D (ng/mL) | 30 | 32 | 0.70 | 30 | 30 | 0.62 | 30 | 32 | 0.44 |
| |||||||||
Sodium (mmol/L) | 138 | 140 | 0.11 | 139 | 139.5 | 0.63 | 139 | 140 | 0.47 |
| |||||||||
Prednisone Dose (mg/kg/day) | 0.08 | 0.1 | 0.79 | 0.07 | 0.19 | 0.032 | 0.07 | 0.16 | 0.71 |
| |||||||||
Platelet Count (K/μL) | 235 | 307 | 0.0065 | 239 | 241 | 0.76 | 239 | 336 | 0.0025 |
| |||||||||
CRP (mg/L) | 1.88 | 0.7 | 0.023 | 1.77 | 0.81 | 0.17 | 1.7 | 0.76 | 0.41 |
| |||||||||
C3 (mg/dL) | 134.3 | 131.5 | 0.28 | 135 | 116 | 0.0073 | 133.4 | 128 | 0.67 |
| |||||||||
Sex | |||||||||
Male | 132 | 13 | 0.041 | 130 | 15 | 0.6665 | 140 | 5 | 0.11 |
Female | 93 | 20 | 104 | 9 | 103 | 10 | |||
| |||||||||
Smoking History | |||||||||
Yes | 83 | 14 | 88 | 9 | 92 | 5 | |||
No | 135 | 16 | 0.43 | 138 | 13 | 1.00 | 143 | 8 | 1.00 |
Unknown | 7 | 3 | 8 | 2 | 8 | 2 | |||
| |||||||||
Alcohol History | |||||||||
Yes | 152 | 13 | 152 | 13 | 159 | 6 | |||
No | 64 | 17 | 0.0061 | 72 | 9 | 0.48 | 74 | 7 | 0.13 |
Unknown | 9 | 3 | 10 | 2 | 10 | 2 | |||
| |||||||||
Physical Activity | |||||||||
Normal | 51 | 4 | 0.01 | 51 | 4 | 0.52 | 54 | 1 | 0.15 |
Fairly Normal | 110 | 16 | 114 | 12 | 117 | 9 | |||
Fairly Inactive | 30 | 1 | 30 | 1 | 30 | 1 | |||
Inactive | 25 | 11 | 31 | 5 | 32 | 4 | |||
| |||||||||
Normal or Fairly Normal | 161 | 20 | 0.20 | 165 | 16 | 1.00 | 171 | 10 | 0.56 |
Inactive or Fairly Inactive | 55 | 12 | 61 | 6 | 62 | 5 | |||
| |||||||||
Nutrition | |||||||||
Well-Nourished | 155 | 12 | 157 | 10 | 162 | 5 | |||
Suspected Malnutrition | 52 | 14 | <0.0001 | 59 | 7 | 0.0011 | 60 | 6 | 0.0002 |
Severe Malnutrition | 8 | 6 | 9 | 5 | 10 | 4 | |||
| |||||||||
Well-Nourished | 155 | 12 | 0.0002 | 157 | 10 | 0.030 | 162 | 5 | 0.0076 |
Malnutrition | 60 | 20 | 68 | 12 | 70 | 10 | |||
| |||||||||
Anti-Depressant | |||||||||
Yes | 65 | 12 | 0.42 | 67 | 10 | 0.24 | 70 | 7 | 0.15 |
No | 160 | 21 | 167 | 14 | 173 | 8 | |||
| |||||||||
Yesb | |||||||||
SSRI | 42 | 10 | 0.32 | 44 | 8 | 0.48 | 46 | 6 | 0.42 |
Other | 23 | 2 | 23 | 2 | 24 | 1 | |||
| |||||||||
SSRIc | |||||||||
Yes | 42 | 10 | 0.16 | 44 | 8 | 0.11 | 46 | 6 | 0.088 |
No | 183 | 23 | 190 | 16 | 197 | 9 | |||
| |||||||||
Proton Pump Inhibitor | |||||||||
Yes | 118 | 17 | 1.00 | 125 | 10 | 0.29 | 125 | 10 | 0.30 |
No | 107 | 16 | 109 | 14 | 118 | 5 | |||
| |||||||||
Anti-Resorptive | |||||||||
Yes | 34 | 15 | 0.0002 | 45 | 4 | 1.00 | 44 | 5 | 0.17 |
No | 191 | 18 | 189 | 20 | 199 | 10 |
All comparisons for continuous variables were performed using the Wilcoxon rank sum test. All comparisons for dichotomous variables were performed using Fisher's Exact Test. All comparisons for ordered categorical variables were performed using the Cochrane-Armitage Test. All p-values are two-tailed and are presented without adjustment for multiple comparisons. Tests for which p<0.005 (bold) should be considered statistically significant while tests for which 0.005<p<0.05 (italics) may be considered as exhibiting strong trends toward statistical significance.
Abbreviations: OP–osteoporosis, CRP–C-reactive protein, C3–complement component 3, SSRI–selective serotonin reuptake inhibitor
Definition of average NIH organ score is as follows: sum of all NIH organ scores (per NIH organ staging; 28) divided by number of organs assessed (7 for men, 8 for women).
Comparison of patients currently taking SSRI vs. patients taking non-SSRI anti-depressant.
Comparison of patients currently taking SSRI vs. patients taking non-SSRI or no anti-depressant.